GENE ONLINE|News &
Opinion
Blog

Ono Pharmaceutical
R&D Opdivo
Taiwan Greenlights BMS, Ono’s Opdivo For Frontline Esophageal Cancer
2022-07-20
Asia-Pacific Neurodegenerative Disease
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18
Anti-epileptic Drug
South Korean Biotech Finds Strategic Partner to Advance Epileptic Treatment Options
2020-10-15
Trials & Approvals PD-L1
BMS Enters Esophageal Cancer Therapy Area Amidst High Competition
2020-09-27
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top